aTyr Pharma Inc (NASDAQ:LIFE)

U.S. Markets are not yet open, but LIFE is being traded in the pre-market session. Pre-Market quote »
18.52
Delayed Data
As of Jun 30
 -0.33 / -1.75%
Today’s Change
12.90
Today|||52-Week Range
28.29
-61.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$437.7M

Company Description

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.

Contact Information

aTyr Pharma, Inc.
3545 John Hopkins Court
San Diego California 92121
P:(858) 731-8389
Investor Relations:

Employees

Shareholders

Individual stakeholders45.54%
Other institutional18.36%
Mutual fund holders0.28%

Top Executives

John D. MendleinExecutive Chairman & Chief Executive Officer
Frédéric ChéreauPresident & Chief Operating Officer
Kelly BlackburnVice President-Clinical Affairs
David M. WeinerChief Medical Officer
John C. McKewVice President-Research

To view my watchlist

Not a member yet?

Sign up now for a free account